brand name exherin small cyclic pentapeptide vasculartargeting drug developed adherex technologies selectively competitively binds blocks ncadherin may result disruption tumor vasculature inhibition tumor cell growth induction tumor cell endothelial cell ncadherin cell surface transmembrane glycoprotein cadherin superfamily proteins involved calciummediated adhesion signaling may upregulated aggressive tumors endothelial cells pericytes tumor blood adherex nci formed clinical trial agreement stating nci sponsor clinical trials variety cancer types received orphan drug status fda pilot study phase trial intravenous pretreatment chemotherapy metastatic melanoma completely destroyed tumors half patients investigated advanced extremity melanoma phase ii antineoplastic immunomodulatory drug article stub help wikipedia expanding